Comparison of renal adverse drug reactions (ADRs) between rofecoxib and celecoxib based the WHO/UMC safety database.

被引：0
|
作者：
Zhao, S
Reynolds, M
Lefkowith, JB
Whelton, A
Arellano, FM
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2001年 / 44卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1592
引用
收藏
页码：S318 / S318
页数：1
相关论文
共 30 条
  • [1] Comparison of cardiovascular (CV) adverse drug reactions (ADRs) between rofecoxib and celecoxib based on the WHO/UMC safety database.
    Zhao, S
    Reynolds, M
    Lefkowith, JB
    Whelton, A
    Arellano, FM
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S316 - S316
  • [2] A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization Uppsala Monitoring Centre safety database
    Zhao, SZ
    Reynolds, MW
    Lefkowith, J
    Whelton, A
    Arellano, FM
    CLINICAL THERAPEUTICS, 2001, 23 (09) : 1478 - 1491
  • [3] Comparison of WHO-UMC and Naranjo Scales for Causality Assessment of Reported Adverse Drug Reactions
    Pandit, Sukant
    Soni, Dhruve
    Krishnamurthy, Bhaskar
    Belhekar, Mahesh N.
    JOURNAL OF PATIENT SAFETY, 2024, 20 (04) : 236 - 239
  • [4] A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions
    Belhekar, Mahesh N.
    Taur, Santosh R.
    Munshi, Renuka P.
    INDIAN JOURNAL OF PHARMACOLOGY, 2014, 46 (01) : 117 - 120
  • [5] Adverse Drug Reactions Reported for Children: What are the Differences Between the FDA AERS and the WHO-UMC VigiBase?
    De Bie, S.
    Li, Y.
    Ferrajolo, C.
    Verhamme, K. M. C.
    Bonhoeffer, J.
    Wong, I. C. K.
    Sturkenboom, M. C. J. M.
    DRUG SAFETY, 2012, 35 (10) : 942 - 943
  • [6] Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions
    Shukla, Ajay K.
    Jhaj, Ratinder
    Misra, Saurav
    Ahmed, Shah N.
    Nanda, Malaya
    Chaudhary, Deepa
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2021, 10 (09) : 3303 - 3308
  • [7] Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions
    Bonaldo, Giulia
    Andriani, Luisa Anna
    D'Annibali, Ottavio
    Motola, Domenico
    Vaccheri, Alberto
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (11) : 1457 - 1463
  • [8] Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions
    Monaco, Luca
    Biagi, Chiara
    Conti, Valentino
    Melis, Mauro
    Donati, Monia
    Venegoni, Mauro
    Vaccheri, Alberto
    Motola, Domenico
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (07) : 1532 - 1543
  • [9] Associations between venous thromboembolism and antipsychotics -: A study of the WHO database of adverse drug reactions
    Hagg, Staffan
    Bate, Andrew
    Stahl, Malin
    Spigset, Olav
    DRUG SAFETY, 2008, 31 (08) : 685 - 694
  • [10] Associations between venous thromboembolism and antipsychotics: A study of the WHO database of adverse drug reactions
    Hägg S.
    Bate A.
    Stahl M.
    Spigset O.
    Drug Safety, 2008, 31 (8) : 685 - 694
123